Your browser doesn't support javascript.
loading
Fear of cancer recurrence and associated factors in family caregivers of patients with hematologic malignancy receiving chemotherapy: A latent profile analysis.
Sheng, Li; Zhu, Yingying; Liu, Yajiao; Hua, Haiying; Zhou, Jingfen; Ye, Long.
Afiliación
  • Sheng L; Wuxi School of Medicine, Jiangnan University, Wuxi, China.
  • Zhu Y; Wuxi School of Medicine, Jiangnan University, Wuxi, China.
  • Liu Y; Nursing Department, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Hua H; Wuxi School of Medicine, Jiangnan University, Wuxi, China.
  • Zhou J; Department of Hematology, Affiliated Hospital of Jiangnan University, Wuxi, China.
  • Ye L; Department of Hematology, Affiliated Hospital of Jiangnan University, Wuxi, China.
Asia Pac J Oncol Nurs ; 11(4): 100382, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38495640
ABSTRACT

Objective:

This study identified the potential subgroups of fear of cancer recurrence (FCR) in family caregivers (FCs) of patients with hematologic malignancies receiving chemotherapy, as well as exploring factors associated with subgroups.

Methods:

This was a cross-sectional study involving 206 pairs of participating patients with hematologic malignancies receiving chemotherapy and their FCs. Using Mplus 8.3 to perform the latent profile analysis of FCs' FCR, the FCs' burden, quality of life, psychological resilience, and anxiety as well as their demographic characteristics were compared between the subgroups, with a logistic regression analysis being applied to examine the factors associated with the FCR subgroups.

Results:

A total of 206 FCs were classified into two subgroups "a low level of FCR" (Class 1, 65.4%) and "a high level of FCR" (Class 2, 34.6%). Quality of life, anxiety, and frequency of chemotherapy were significantly associated with the two subgroups.

Conclusions:

FCs of patients with hematologic malignancy receiving chemotherapy had two FCR subgroups, "a low level of FCR" and "a high level of FCR", in association with quality of life, anxiety, and frequency of chemotherapy. These findings provide the theoretical foundations for screening the FCR factor of FCs and conducting interventions for them.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Asia Pac J Oncol Nurs Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Asia Pac J Oncol Nurs Año: 2024 Tipo del documento: Article País de afiliación: China